Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-05

FDA Approved: LOMOTIL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for Lomotil (diphenoxylate hydrochloride and atropine sulfate) from Pfizer Laboratories Div Pfizer Inc under NDA 012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOMOTIL (Diphenoxylate hydrochloride and atropine sulfate)

Snippet

SUPPL AP for LOMOTIL (DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE)